Surgical Sutures Market is forecasted to grow from $4.0 billion in 2023 to $5.5 billion by 2028, at a CAGR of 6.4% according to MarketsandMarkets. This growth is primarily driven by the aging population and rising prevalence of chronic diseases, increasing the demand for surgical procedures. Technological innovations in suture materials are providing healthcare professionals with advanced tools for wound closure. However, regulatory constraints and price pressures due to the availability of alternative wound closure methods remain significant challenges for market players.
Download an Illustrative overview
Browse in-depth TOC on “Surgical Sutures Market”
348 – Tables
52 – Figures
319 – Pages
The hospital segment is expected to register a substantial share by end users of the Surgical Sutures market.
Hospitals play a pivotal role as end users in the surgical suture market, holding a substantial share. This dominance is rooted in the extensive and diverse range of surgical procedures conducted within hospital settings, ranging from routine surgeries to complex interventions. The consistent demand for surgical sutures in these environments underscores their critical role in wound closure and patient recovery. Additionally, hospitals often serve as central hubs for medical care, contributing to the heightened utilization of surgical sutures. As the healthcare landscape continues to evolve, the significance of hospitals as key end users in the surgical suture market remains pronounced, influencing market dynamics and trends.
Multifilament Surgical Sutures hold a substantial share by type in Surgical Sutures market.
Multifilament surgical sutures have emerged as a dominant force in the surgical suture market, securing a substantial share by type. This prominence is attributed to the distinct advantages offered by multifilament sutures in comparison to their monofilament counterparts. Characterized by multiple strands twisted or braided together, multifilament sutures boast enhanced flexibility, knot security, and ease of handling for surgeons. These attributes make them particularly well-suited for a wide range of surgical applications. The multifilament variety’s ability to minimize tissue reaction and inflammation, coupled with its superior tensile strength, further solidifies its position as a preferred choice among healthcare professionals. As surgical techniques evolve and demand for precise and reliable wound closure solutions grows, multifilament surgical sutures continue to play a pivotal role in shaping the landscape of the surgical suture market.
Asia is to witness a considerable growth rate during the forecast period.
In the upcoming years, the surgical suture market in Asia is set to experience significant growth. This growth is driven by factors such as a growing population, an increase in chronic diseases, and a rise in the number of surgical procedures. Governments in the region are also investing more in healthcare infrastructure, making surgeries more accessible. Big countries like China and India are expected to be major contributors to this growth, with a rising awareness of advanced medical treatments. The popularity of medical tourism in countries like India and Singapore is adding to this momentum. As Asia continues to develop economically and improve its healthcare services, the surgical suture market is likely to see substantial and sustained growth in the region.
Surgical Sutures Market Dynamics:
Drivers:
- Rising surgical procedures and trauma cases to drive the market
- Aging population, chronic diseases and rice in surgical procedures to drive the market
Restraints:
- Availability of Alternative Wound Closure Methods
Opportunities:
- Low and Middle-Income Countries have opportunities for growth of this market
Challenge:
- High Market Competition and Pricing Pressures
Key Market Players of Surgical Sutures Industry:
Prominent players in the surgical sutures market include Ethicon, Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic Plc (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), Healthium MedTech Limited (India), Peters Surgical (France), Corza Medical (US), Boston Scientific Corporation (US), DemeTECH Corporation (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Smith & Nephew Plc (UK), CONMED Corporation (US), Mellon Medical B.V. (Netherlands), Unisur Lifecare Pvt. Ltd. (India), Assut Europe (UK), Katsan Katgüt Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Aqmen Medtech Pvt. Ltd. (India), Futura Surgicare Pvt. Ltd. (India), Anchora Medical Ltd. (Israel), Lotus Surgicals (India), Biosintex (Romania), and Meril Life Sciences Pvt. Ltd. (India).
Get 10% Free Customization on this Report
Surgical Sutures Market Recent Developments:
- In January 2023, Ethicon, Inc. partnered with Microsoft (US) to further expand its digital surgery solutions.
- In March 2023, Medtronic plc (Ireland) signed a contract with Vizient (US) for the Touch Surgery Enterprise, allowing surgeons to use data to refine how surgery is taught and executed.
- In December 2021, DKSH (Switzerland) expanded its partnership with Healthium MedTtech Limited. This partnership will help Healthium to provide its products in Thailand, Cambodia, and Laos.
- In June 2021, Healthium acquired VitalCare (UK), a manufacturer of urology consumable care products, through its subsidiary Clinisupplies Ltd. With this acquisition, Healthium strengthened its presence in the urology segment in Europe and the US.
Content Source:
https://www.marketsandmarkets.com/Market-Reports/surgical-sutures-market-18374832.html
https://www.marketsandmarkets.com/PressReleases/surgical-sutures.asp
